FMP

FMP

Enter
API Tools
API DocumentationAPI Viewer
Pricing
Blog
How To
Education
Index ArticlesForexFinancial RatiosCryptoFinancial AnalysisOther
Market NewsDiscounted Cash FlowDeveloper
Screener
Most Searched StocksForeign Exchange RatesCryptocurrenciesMarket IndexesMarket Top GainersMarket Top LosersMarket Highest VolumeSector Performance
Extras
Resources
Formula Methodologies
Financial FormulasParsing StatementsDCF FormulaPiotroski ScoreOwner EarningsRecommendations Formula
Excel/Sheets Add-on
Excel Add-onGoogle Sheet Add-on
API Updates
ChangelogAPI StatusCycle Times
CareersAffiliate ProgramFAQs
Sign InSign Up

LRMR - Larimar Therapeutics...

photo-url-https://images.financialmodelingprep.com/symbol/LRMR.png

Larimar Therapeutics, Inc.

LRMR

NASDAQ

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

4.01 USD

0.03 (0.748%)

OverviewProfileFinancial StatementsFinancial RatiosChartAnalysisNewsCorporate ActionsDCF

LRMR Ratings

page loading card

Upgrades & Downgrades

We are unable to load this data!

fmp-logo

Price Targets

We are unable to load the data!

fmp-logo
FMP

FMP

FMP

HomeTerms of ServicePrivacy PolicyBlogCareersFAQsContact Us

API

DocumentationPricingFormulasMarket Indexes
Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep